Detalhe da pesquisa
1.
Australian recommendations on tapering of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in inflammatory arthritis.
Intern Med J
; 52(10): 1799-1805, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35567366
2.
What does digitalization hold for the creation of real-world evidence?
Rheumatology (Oxford)
; 59(1): 39-45, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31834405
3.
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD).
Ann Rheum Dis
; 2024 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38811050
4.
Trajectories of self-reported pain-related health outcomes and longitudinal effects on medication use in rheumatoid arthritis: a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD).
RMD Open
; 9(3)2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37507204
5.
Using the derived 28-joint disease activity score patient-reported components (DAS28-P) index as a discriminatory measure of response to disease-modifying anti-rheumatic drug therapy in early rheumatoid arthritis.
BMC Rheumatol
; 6(1): 67, 2022 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36376988
6.
Efficacy and safety of urate-lowering therapy in people with kidney impairment: a GCAN-initiated literature review.
Rheumatol Adv Pract
; 5(1): rkaa073, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33521512
7.
Efficacy and safety of gout flare prophylaxis and therapy use in people with chronic kidney disease: a Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN)-initiated literature review.
Arthritis Res Ther
; 23(1): 130, 2021 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33910619
8.
Management of gout in chronic kidney disease: a G-CAN Consensus Statement on the research priorities.
Nat Rev Rheumatol
; 17(10): 633-641, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34331037
9.
Improving benefit-harm assessment of glucocorticoid therapy incorporating the patient perspective: The OMERACT glucocorticoid core domain set.
Semin Arthritis Rheum
; 51(5): 1139-1145, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34253398
10.
How the weather affects the pain of citizen scientists using a smartphone app.
NPJ Digit Med
; 2: 105, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31667359
11.
Gout prevalence and predictors of urate-lowering therapy use: results from a population-based study.
Arthritis Res Ther
; 20(1): 143, 2018 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29996922